This inventor holds 1 USPTO granted patent. Top assignees: Chinese Academy of Sciences, Shanghai Lead Discovery Pharmaceuticals Limited Company. Active years: 2010.
Company Filing History:
1 out of 3,334 
1 out of 1 Years Active: 2010
Title: Yifu Yang: Innovator in SARS Research
Introduction
Yifu Yang is a prominent inventor based in Shanghai, China. He is known for his significant contributions to the field of virology, particularly in the study of the SARS coronavirus. His innovative work has led to the development of a crucial patent that addresses the challenges posed by this virus.
Latest Patents
Yifu Yang holds a patent for a 3D-structure model of the SARS coronavirus 3CL protease and anti-SARS drugs. This invention discloses the 3D structure of the SARS-CoV Viral 3CL Protease obtained through molecular simulation. The 3D structure serves as a drug target for screening the existing medical database CMC (Comprehensive Medicinal Chemistry, MDL Information System, Inc.). Through this research, a group of compounds that inhibit the SARS-CoV virus 3CL Protease has been identified. Notably, Cinanserin was tested at both molecular and viral levels, demonstrating its ability to inhibit the SARS-CoV viral 3CL protease and the virus itself. Additionally, Cinanserin analogs were synthesized and tested, showing potential for treating and/or preventing SARS-CoV virus infection. Yifu Yang has been granted 1 patent for this groundbreaking work.
Career Highlights
Throughout his career, Yifu Yang has worked with notable organizations, including Shanghai Lead Discovery Pharmaceuticals Limited Company and the Chinese Academy of Sciences. His research has significantly advanced the understanding of viral mechanisms and potential therapeutic interventions.
Collaborations
Yifu Yang has collaborated with esteemed colleagues such as Jingkang Shen and Hualiang Jiang. Their joint efforts have contributed to the progress in the field of antiviral research.
Conclusion
Yifu Yang's innovative work in developing a 3D-structure model of the SARS coronavirus 3CL protease has opened new avenues for drug discovery and treatment strategies. His contributions are vital in the ongoing fight against viral infections.